Name: HOOKIPA PHARMA INC (HOOK) Stock
Brand: HOOKIPA PHARMA INC
Rating: 2.5 (3 reviews)

HOOK Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

a month ago - By: HOOKIPA Pharma Inc. - Mentions: LSE -

HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead

5 months ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

5 months ago - By: HOOKIPA Pharma Inc. - Mentions: LSE -

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

a year ago - By: BusinessInsider

HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024

6 months ago - By: Yahoo Finance - Mentions: GILD

Gilead (GILD) to Acquire HOOK for $10 million

7 months ago - By: Benzinga - Mentions: CVM HSDT LTRN BDSX ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

7 months ago - By: Yahoo Finance - Mentions: WFC F AMD COMP ...

Wells Fargo Maintains a Sell Rating on Ford (F) After Q1 Report

7 months ago - By: Benzinga - Mentions: HCTI NAOV LUNG ARVN ...

12 Health Care Stocks Moving In Thursday's Intraday Session

10 months ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)

10 months ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

10 months ago - By: HOOKIPA Pharma Inc. - Mentions: LSE -

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

a year ago - By: HOOKIPA Pharma Inc.

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc - FORM 8 (OPD)

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

a year ago - By: HOOKIPA Pharma Inc. - Mentions: LSE -

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

a year ago - By: HOOKIPA Pharma Inc.

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment

a year ago - By: HOOKIPA Pharma Inc.

Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

a year ago - By: Kaskela Law LLC

Kaskela Law LLC Announces Shareholder Investigation of HOOKIPA Pharma Inc. (NASDAQ: HOOK) and Encourages Investors to Contact the Firm

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Board of Directors Changes

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Board of Directors Changes

a year ago - By: InvestorPlace

HOOK Stock Earnings: HOOKIPA Pharma Misses EPS, Misses Revenue for Q2 2024

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights

a year ago - By: HOOKIPA Pharma Inc.

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

a year ago - By: HOOKIPA Pharma Inc. - Mentions: ARVN GMDA

HOOKIPA PHARMA INC (HOOK) Stock News

HOOK Latest News, Press Relases and Analysis